UK approves Pfizer jab for use in 12-15-year-olds
UK claimed that the vaccine is safe and effective in this age group and that the benefits outweigh the risks
The United Kingdom has approved the use of the Pfizer-BioNTech covid-19 vaccine for children aged 12 to 15.
UK claimed that the vaccine is safe and effective in this age group and that the benefits outweigh the risks, reports BBC.
Medicines and Healthcare products Regulatory Agency (MHRA) stated that the vaccination had undergone a "rigorous review" in adolescents.
Keep updated, follow The Business Standard's Google news channel
The vaccinations committee in the United Kingdom will now decide whether or not youngsters should receive the vaccination.
The Pfizer vaccine is already authorised for persons over the age of 16.
The vaccine's safety in children aged 12 to 15 will be closely watched, according to Dr June Raine, chief executive of the MHRA.
"No extension to an authorisation would be approved unless the expected standards of safety, quality and effectiveness have been met," she said.
The Joint Committee on Vaccination and Immunisation (JCVI) must now advise the government on whether this age group should be vaccinated as part of the UK rollout.
